Viewing Study NCT06718205


Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2026-03-05 @ 2:37 PM
Study NCT ID: NCT06718205
Status: RECRUITING
Last Update Posted: 2024-12-05
First Post: 2024-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma
Sponsor: The First Affiliated Hospital of Zhengzhou University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module